Chemokines: Leucocyte recruitment and activation cytokines

Lancet

Volumn 349, Issue 9050, 1997, Pages 490-495

  Adams, David H ^a   Lloyd, Andrew R ^b,c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c PRINCE HENRY HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE;

ANGIOGENESIS; ANTIMICROBIAL ACTIVITY; CELLULAR IMMUNITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; INFLAMMATION; LEUKOCYTE; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; PRIORITY JOURNAL; PROTEIN FAMILY; SHORT SURVEY;

EID: 0031040539     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)07524-1     Document Type: Review

References (51)

1. Schall TJ, Bacon KB. Chemokines, leucocyte trafficking, and inflammation. Curr Opin Immunol 1994; 6: 865-73.
2. Wells TNC, Power CA, Lustinarasimhan M, et al. Selectivity and antagonism of chemokine receptors. J Leukoc Biol 1996; 59: 53-60.
3. Baggiolini M, Loetscher P, Moser B. Interleukin-8 and the chemokine family. Int J Immunopharmacol 1995; 17: 103-08.
4. Kelner GS, Kennedy J, Bacon KB, et al. Lymphotactin - a cytokine that represents a new class of chemokine X. Science 1994; 266: 1395-99.
5. Baggiolini M, Dewald D, Moser B. Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. Adv Immunol 1994; 55: 97-179.
6. Sylvester I, Suffredini AF, Boujoukos AJ, et al. Neutrophil attractant protein-1 and monocyte chemoattractant protein-1 in human serum. Effects of intravenous lipopolysaccharide on free attractants, specific IgG autoantibodies and immune complexes. J Immunol 1993; 151: 3292-98.
7. Luscinskas FW, Kiely JM, Ding H, et al. In vitro inhibitory effect of IL-8 and other chemoattractants on neutrophil-endothelial adhesive interactions. J Immunol 1992; 149: 2163-71.
8. Van Zee KJ, Fischer E, Hawer AS, et al. Effects on intravenous IL-8 administration in nonhuman primates. J Immunol 1992; 148: 1746-52.
9. Furie MB, Randolph GJ. Chemokines and tissue injury. Am J Pathol 1995; 146: 1287-301.
10. Benbaruch A, Michiel DF, Oppenheim JJ. Signals and receptors involved in recruitment of inflammatory cells. J Biol Chem 1995; 270: 11703-06.
11. Alcami A, Smith GL. Cytokine receptors encoded by poxviruses - a lesson in cytokine biology. Immunol Today 1995; 16: 474-78.
12. Ahuja SK, Gao J, Murphy PM. Chemokine receptors and molecular mimicry. Immunol Today 1994; 15: 281-87.
13. Springer TA. Traffic signals for lymphocyte recirculation and leucocyte emigration: the multistep paradigm. Cell 1994; 76: 301-14.
14. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996; 272: 60-66.
15. Adams DH, Shaw S. Leucocyte endothelial intreactions and regulations and regulation of leucocyte migration. Lancet 1994; 343: 831-36.
16. Tanaka Y, Adama DH, Husscher S, Hirano H, Siebenlist U, Shaw S. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1b. Nature 1993; 361: 79-82.
17. Taub DD, Conlon K, Lloyd AR, Oppenheim JJ, Kelvin DJ. Preferential migration of activated human CD4+ and CD8+ T cells in response to MIP-1α and MIp-1β. Science 1993; 260: 355-58.
18. Ebnet K, Kaldijian EP, Anderson AO, Shaw S. Orchestrated information-transfer underlying leucocyte-endothelial interactions. Annu Rev Immunol 1996; 14: 155-77.
19. Witt DP, Lander AD. Differential binding of chemokines to glycosaminoglycan subpopulations. Curr Biol 1994; 4: 394-400.
20. Ponath PD, Qin S, Ringler DJ, et al. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 1996; 97: 604-12.
21. Erger RA, Casale TB. Interleukin-8 is a potent mediator of eosinophil chemotaxis through endothelium and epithelium. Am J Physiol Lung Cell Molec Physiol 1995; 12: L 117-L 122.
22. Strieter RM, Standiford TJ, Huffnagle GB, Colleti LM, Lukacs NW, Kunkel SL. The good, the bad, and the ugly - the role of chemokines in models of human-disease. J Immunol 1996; 156: 3583-86.
23. Graham GJ, Wright EG, Hewick R, et al. Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature 1990; 344: 442-444.
24. Bacon KB, Premack BA, Gardner P, Schall TJ. Activation of dual T-cell signaling pathways by the chemokine RANTES. Science 1995; 269: 1727-1730.
25. Taub DD, Turcovskicorrales SM, Key ML, Longo DL, Murphy WJ. Chemokines and T-lymphocyte activation 1 beta chemokines costimulate human T-lymphocyte in-vitro. J Immunol 1996; 156: 2095-103.
26. Taub DD, Ortaldo JR, Turcovskicorrales SM, Key ML, Longo DL, Murphy WJ. Beta-chemokines costimulate T-lymphocyte cytolysis, proliferation, and lymphokine production. J Leukoc Biol 1996; 59: 81-89.
27. Steiter RM, Polverini PJ, Arenberg D A, Kunkel SL. The role of CxC chemokines as regulators of angiogenesis. Shock 1995; 4: 155-60.
28. Stieter RM, Polverini PJ, Kunkel SL, et al. The functional-role of the ELR motif in CxC chemokine-mediated angiogenesis. J Biol Chem 1995; 270: 27348-57.
29. Karakurum M, Shreeniwas R, Chen J, et al. Hypoxic induction of interleukin-8 gene-expression in human endothelial-cells. J Clin Invest 1994; 93: 1564-70.
30. Colletti LM, Kunkel SL, Walz A, et al. Cemokine expression during hepatic ischaemia reperfusion-induced lung injury in the rat. J Clin Invest 1995; 95: 134-141.
31. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-09.
32. Schall T. The chemokines. In: Thompson AW, ed. The cytokine handbook, 2nd edn. London: Academic Press, 1994: 419-59.
33. Azuma H, Tilney NL. Chronic graft-rejection. Curr Opin Immunol 1994; 6: 770-76.
34. Adams DH, Afford SA, Fear J, Shaw S, Hubscher SG. Hepatic expression of macrophage inflammatory protein-1β after liver transplantation. Transplantation 1996; 61: 817-25.
35. Kunkel SL, Lukacs N, Kasama T, Strieter RM. The role of chemokines in inflammatory joint disease. J Leukoc Biol 1996; 59: 6-12.
36. Lukacs MW, Strieter RM, Chensue SW, Kunkel SL. Activation and regulation of chemokines in allergic airway inflammation. J Leukoc Biol 1996; 59: 13-17.
37. Zhang YH, Broser M, Cohen H, et al. Enhanced interleukin-8 release and gene-expression in macrophages after exposure to mycobacterium-tuberculosis and its components. J Clin Invest 1995; 95: 586-92.
38. Cook DN, Beck MA, Coffman TM, et al. Requirement of MIP-1α for an inflammatory response to viral infection. Science 1995; 269: 1583-85.
39. Cocchi F, Devico AL, Garzinodemo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP1-alpha, and MIP1-beta as the major HIV-suppressive factors produced by CD8(+) T-cells. Science 1995; 270: 1811-15.
40. Tedla N, Palladinetti P, Kelly M, et al. Chemokines and T-lymphocyte recruitment to lymph-nodes in HIV-infection. Am J Pathol 1996; 148: 1367-73.
41. Schmidtmayerova H, Nottet HSLM, Nuovo G, et al. Human-immunodeficiency-virus type-1 infection alters chemokine beta-peptide expression in human monocytes - implications for recruitment of leukocytes into brain and lymph-nodes. Proc Nat Acad Sci USA 1996; 93: 700-04.
42. Dragic T, Litwin V, Allaway GP, et al. HIV-1 entry into CD4(+) cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996; 381: 667-73.
43. Deng HK, Liu R, Ellmeier W, et al. Identification of a major coreceptor for primary isolates of HIV. Nature 1996; 381: 661-66.
44. Choe H, Farzan M, Sun Y, et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996; 85: 1135-48.
45. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor -functional cDNA cloning of a 7-transmembrane, G-protein-coupled receptor. Science 1996; 272: 872-77.
46. Bleul CC, Farzan M, Chloe H, et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996; 382: 829-33.
47. Oberlin E, Amara A, Bachelerie F, et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996; 382: 833-35.
48. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86: 367-77.
49. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382: 722-25.
50. Sekido N, Mukaida N, Harada A, Nakanishi I, Watanabe Y, Matsushima K. Prevention of lung reperfusion injury in rabbits by a monoclonal-antibody against interleukin-8. Nature 1993; 365: 654-57.
51. Graham GJ, Mackenzie J, Lowe S, et al. Aggregation of the chemokine MIP-1-alpha is a dynamic and reversible phenomenon-biochemical and biological analyses. J Biol Chem 1994; 269: 4974-78.